Records 1 - 7
| Polymorphisms of NF-?B pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.
The pharmacogenomics journal 2019 Oct .
Xin Shuang, Zhao Yuanyuan, Wang Changzheng, Huang Yan, Zhuang Wei, Ma Yuxiang, Huang Min, Xu Xun, Wang Xueding, Zhang
| NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.
Oncotarget 2016 Dec .
Fu Wen, Zhuo Zhen-Jian, Chen Yung-Chang, Zhu Jinhong, Zhao Zhang, Jia Wei, Hu Jin-Hua, Fu Kai, Zhu Shi-Bo, He Jing, Liu Guo-Cha
| Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Nov .
Yin Jiaoyang, Wang Huiwen, Vogel Ulla, Wang Chunhong, Hou Wei, Ma Yega
| NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population.
Gene 2015 Aug 567 (1): 31-5.
Yin Jiaoyang, Yin Mengfan, Vogel Ulla, Wu Yuhong, Yao Tao, Cheng Yanhua, Sun Zhenxiang, Hou Wei, Wang Chunho
| The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population.
International journal of clinical and experimental medicine 2015 8 (5): 8153-7.
Wang Yue, Chen Libo, Pan Liming, Xue Jinru, Yu Haixia
| Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.
Cancer 2012 Nov 118 (22): 5630-6.
Shiels Meredith S, Engels Eric A, Shi Jianxin, Landi Maria Teresa, Albanes Demetrius, Chatterjee Nilanjan, Chanock Stephen J, Caporaso Neil E, Chaturvedi Anil
| Polymorphisms in NF-?B pathway genes & their association with risk of lung cancer in the Chinese population.
Pakistan journal of medical sciences 0 31 (6): 1411-6.
Zhang Jing-Wei, Chen Qiu-Sheng, Zhai Jian-Xia, Lv Peng-Ju, Sun Xiao-Y